Human lysozyme gene mutations cause hereditary systemic amyloidosis
Mark B. Pepys(University College London), J. Justin Hsuan(The Royal Free Hospital), GA Tennent(Hammersmith Hospital), C. J. Terry(MRC Laboratory of Molecular Biology), Terry Feest(Southmead Hospital), Nicholas F. Totty(Ludwig Cancer Research), C. C. F. Blake(MRC Laboratory of Molecular Biology), A. M. Zalin(Wordsley Hospital), David M. Vigushin(Hammersmith Hospital), Ong Nam Phuong Nguyen(Ludwig Cancer Research), Philip N. Hawkins(The Royal Free Hospital), Anne K. Soutar(Hammersmith Hospital), David R. Booth(Hammersmith Hospital)
Cited by 660
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k